Search

everythinglearnresearchcommunity

for

Search:↓

Ivarmacitinib significantly improved hair regrowth in severe alopecia areata after tofacitinib was less effective.

Baricitinib is the most effective treatment for alopecia areata.

Higher levels of certain proteins in the blood are linked to more severe patchy alopecia areata.

AMFIBHA scaffold significantly healed large full-thickness burn wounds in rabbits and restored skin's mechanical properties.

Scientists found a new protein, AMY117, common in Alzheimer's patients, which could be important for treatment and diagnosis.

Activating Notch signaling can kill basal cell carcinoma cells.

Frontal fibrosing alopecia is linked to increased immune system activity and reduced stem cells, suggesting early treatment targeting this pathway might prevent hair follicle damage.

No effective treatment exists to stimulate hair growth in atrichia with papular lesions.

AGC2-1 protein is essential for root hair growth in Arabidopsis.

Keratin-associated proteins help link filaments and affect keratin's strength.

Baricitinib helps regrow hair in adults with severe alopecia better than a placebo and is approved for treatment, but long-term effects are still unknown.

TGF-β1 increases androgen receptor activity in hair loss, but Hic-5/ARA55 can counter this effect.

Disruptions in mammary stem cell division can lead to cancer, but targeting these processes might help treat breast cancer.

Accurate diagnosis of APL is crucial to avoid unnecessary treatments.

Baricitinib helps alopecia areata and may improve psoriasis, but its effect on psoriatic arthritis is unclear.

Tofacitinib, a hair regrowth treatment, may worsen acne.

SADBE treatment led to complete hair regrowth in mice with alopecia areata by altering immune cell movement.

Proper niche formation in Drosophila requires Slit-Robo signaling for cell migration.

iNKT cells can help prevent and treat alopecia areata by promoting hair regrowth.

The Agouti gene influences pigmentation and may have a developmental role in deer mice.

Baricitinib was effective in treating severe and very severe alopecia areata after 52 weeks.

The new ECM patch greatly improves wound healing and tissue regeneration.

Integrating ABI screening in clinics can improve patient care for those at risk of peripheral artery disease.

Oral Janus kinase inhibitors are effective for treating alopecia areata in adults.

Combination therapy, including JAK inhibitors, effectively regrows hair and reduces severity in Black children with stubborn Alopecia Areata.

Thymosin β4 helps with healing, inflammation, and organ protection.

Janus hydrogels improve medical adhesives by mimicking natural barriers for better tissue integration.

JAK inhibitors helped treat hair loss in two people with Down syndrome.